Minute Insight: Abbott Receives US FDA Clearance For Spinal Cord Stimulator

Abbott announced on 19 December that the US Food and Drug Administration has approved its Eterna spinal cord stimulation system (SCS) for treating chronic pain with low-dose BURSTDR stimulation.

Minute Insight
• Source: Informa/Alamy

Abbott claims Eterna is the smallest implantable, rechargeable spinal cord stimulator on the market for treating chronic pain.

It uses Abbott’s proprietary low-dose BURSTDR stimulation, which the company says reduces pain 23% more than traditional waveform technology approaches....

More from Approvals

More from Policy & Regulation